Phillips, G L <br/><br/>
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Jul 2004 
 - 473-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1083-8791 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2004.03.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amifostine--administration & dosage<br/>Cohort Studies<br/>Disease-Free Survival<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Maximum Tolerated Dose<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Neoplasms--therapy<br/>Transplantation, Autologous<br/>Treatment Outcome